What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Magnetic resonance imaging
Matthew L. Senjem spends much of his time researching Alzheimer's disease, Pathology, Internal medicine, Dementia and Magnetic resonance imaging.
Matthew L. Senjem has included themes like Positron emission tomography, Apolipoprotein E, Atrophy and Amyloidosis in his Alzheimer's disease study.
His study in Atrophy is interdisciplinary in nature, drawing from both Frontal lobe, Neuroscience, Cohort and Grey matter.
His Neuroscience research incorporates themes from Voxel-based morphometry and Audiology.
He has researched Pathology in several fields, including Biomarker, Neuroimaging and Brain mapping.
His Internal medicine research incorporates elements of Oncology and Cardiology.
His most cited work include:
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. (828 citations)
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. (735 citations)
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease (442 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Pathology, Dementia, Internal medicine, Alzheimer's disease and Atrophy.
As part of the same scientific family, Matthew L. Senjem usually focuses on Pathology, concentrating on Magnetic resonance imaging and intersecting with Aphasia.
His research investigates the connection with Dementia and areas like Neuroscience which intersect with concerns in Primary progressive aphasia.
As a member of one scientific family, Matthew L. Senjem mostly works in the field of Internal medicine, focusing on Cardiology and, on occasion, Hyperintensity.
His Alzheimer's disease research focuses on Pittsburgh compound B in particular.
His work investigates the relationship between Atrophy and topics such as Grey matter that intersect with problems in Audiology.
He most often published in these fields:
- Pathology (37.05%)
- Dementia (22.59%)
- Internal medicine (21.39%)
What were the highlights of his more recent work (between 2018-2021)?
- Pathology (37.05%)
- Internal medicine (21.39%)
- Dementia (22.59%)
In recent papers he was focusing on the following fields of study:
Matthew L. Senjem focuses on Pathology, Internal medicine, Dementia, Standardized uptake value and Neuroimaging.
His Pathology study integrates concerns from other disciplines, such as Temporal lobe and Grey matter.
His study in Alzheimer's disease and Cohort study is done as part of Internal medicine.
His work deals with themes such as Biomarker, Dementia with Lewy bodies and Cohort, which intersect with Alzheimer's disease.
The concepts of his Dementia study are interwoven with issues in Apolipoprotein E and Putamen.
The Positron emission tomography study combines topics in areas such as Primary progressive aphasia and Magnetic resonance imaging.
Between 2018 and 2021, his most popular works were:
- Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework. (70 citations)
- Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia (70 citations)
- The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes (45 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Magnetic resonance imaging
His main research concerns Pathology, Temporal lobe, Standardized uptake value, Magnetic resonance imaging and Dementia.
He regularly links together related areas like Hyperintensity in his Pathology studies.
While the research belongs to areas of Magnetic resonance imaging, he spends his time largely on the problem of Frontotemporal dementia, intersecting his research to questions surrounding Tau protein, Aphasia, Age of onset and Neuropsychology.
To a larger extent, Matthew L. Senjem studies Internal medicine with the aim of understanding Dementia.
His research in Atrophy intersects with topics in Neurodegeneration and Grey matter.
He combines subjects such as Interquartile range, Cohort study, Dementia with Lewy bodies, Biomarker and Cohort with his study of Alzheimer's disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
